| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Chief Operating Officer | Stock Options (Right to buy) | 81,499 | $1,482,467 | $18.19 | 04 Mar 2025 | Direct |
| NovoCure Ltd | Chief Operating Officer | Ordinary Shares | 78,306 | $1,123,691 | $14.35 | 11 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | 11 Jan 2026 | 1 | -$30,609 | 4 | Chief Operating Officer | 12 Jan 2026, 17:30 |
| NVCR | NovoCure Ltd | 01 Nov 2025 | 2 | -$38,218 | 4 | Chief Operating Officer | 04 Nov 2025, 16:09 |
| NVCR | NovoCure Ltd | 03 May 2025 | 1 | -$10,604 | 4 | Chief Operating Officer | 05 May 2025, 16:17 |
| NVCR | NovoCure Ltd | 04 Mar 2025 | 2 | +$2,482,462 | 4 | Chief Operating Officer | 06 Mar 2025, 16:40 |
| NVCR | NovoCure Ltd | 03 Mar 2025 | 1 | -$4,634 | 4 | Chief Operating Officer | 04 Mar 2025, 16:16 |
| NVCR | NovoCure Ltd | 27 Feb 2025 | 3 | -$39,688 | 4/A | Chief Operating Officer | 03 Mar 2025, 21:26 |
| NVCR | NovoCure Ltd | 11 Jan 2025 | 1 | -$57,906 | 4 | Chief Operating Officer | 15 Jan 2025, 16:23 |
| NVCR | NovoCure Ltd | 02 Nov 2024 | 3 | +$756,102 | 4 | Chief Operating Officer | 06 Nov 2024, 16:27 |
| NVCR | NovoCure Ltd | 01 Nov 2024 | 1 | -$2,540 | 4 | Chief Operating Officer | 04 Nov 2024, 16:32 |
| NVCR | NovoCure Ltd | 01 Oct 2024 | 0 | $0 | 3 | Chief Operating Officer | 09 Oct 2024, 18:21 |